Consensus Abbott Laboratories Deutsche Boerse AG

Stocks

ABL

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 02:02:30 2026-08-28 EDT			5-day change	1st Jan Change
95.46 ^EUR	-2.19%		-1.08%	-9.52%

08-27	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing	MT
08-27	Abbott Laboratories' Stroke Treatment Device Receives CE Mark	MT

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

ef43de8604f62689.j32_CckC2HnB19zueWDrNdoVXvTtiKUho8px6VVnL0I.uTfLeZtxtxOXorbZETPfWJ5CFoSp8cNn0444rSZfQnLnLN5d_0nuEKe-hQ~570fc520d20029c0b5fa829a2a84aa04

Analysts' recommendations: Abbott Laboratories

08-21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
08-13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
07-17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
07-17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
07-17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
07-17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
07-17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
07-16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
07-06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
07-01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
06-12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
05-27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05-05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
04-22	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
04-22	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT
04-21	Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating	MT
04-21	Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating	MT
04-20	Argus Cuts Abbott Laboratories' Price Target to $125 From $140	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+7.72%
	MEDTRONIC PLC					+9.41%
	CENCORA, INC.					+14.97%
	HOYA CORPORATION					+25.35%
	BECTON, DICKINSON AND COMPANY					+3.34%
	DEXCOM, INC.					+5.41%
	MEDLINE INC.					+28.76%
	WEST PHARMACEUTICAL SERVICES, INC.					+16.94%
	TERUMO CORPORATION					+22.39%
	Average					+14.92%
	Weighted average by Cap.					+11.92%